Genmab — November 2017

[bibob]

Det er dog ikke verdens undergang hvis ikke den er med, men det ville sende et stærkt signal.

[JKY_VH]

Nej ikke meget er sikkert i denne verden, men vi håber:-)

[GeorgeBest]

Genmab Announces European Regulatory Submission for Daratumumab in Front Line Multiple Myeloma

[GeorgeBest]

• Application to broaden label for daratumumab in front line multiple myeloma submitted to EMA
• Submission based on data from Phase III ALCYONE study
• Genmab to receive USD 3 million in milestone payments from Janssen

[GeorgeBest]

"We are very pleased about this submission, which marks the first application for the use of daratumumab for patients with newly diagnosed multiple myeloma. We look forward to working with both Janssen and the EMA so that daratumumab can potentially become available for a broader group of multiple myeloma patients," said Jan van de Winkel, Ph.D., Chief Executive Officer of Genmab.

[bibob]

Stærkt GB. Rigtig gode nyheder.

[GeorgeBest]

http://ir.genmab.com/releasedetail.cfm?ReleaseID=1049446

[jkj]

de ville indsende til usa på samme tid, så den må også være på trapperne

[E_L]

Genmab Announces European Regulatory Submission for Daratumumab in Front Line Multiple Myeloma

[E_L]

sorry lol

[bibob]

Good morning E L.

[E_L]

haha

[E_L]

so not FDA; will they wait for Maia?

[JKY_VH]

Tak GB er milestone med i seneste finansielle opdatering?

[E_L]

strange timing by the way, 1 hour before abstracts....

[GeorgeBest]

Jeg ved det ikke JKY, men den er heller ikke så stor.

[JKY_VH]

Tak, nej du har ret, det er "småtingsafdelingen"

[gentogen]

. The milestone payments were included in Genmab's financial guidance for 2017, which was published on November 14, 2017

[JKY_VH]

tak gentogen

[OHW]

..og AB kvitterer med et lille ekstra udsalg, der får aktien ned igen..